A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...

Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...

A metro woman was given a few years to live in 2022, after being diagnosed with a serious lung disease. However, thanks to a double lung transplant, she was given a second chance at life.

Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of ...

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

The most common chronic progressive fibrosing ILD is IPF.1,2 PPF is another form of progressive fibrotic lung disease that ...

For millions of people with COPD, asthma, or lung damage after tuberculosis, the impact of a preventive injection may be a ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

Lung Health Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia The S100 family of proteins plays a pivotal role in the pathogenesis of lung diseases, including asthma, ...

What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is a rare and serious condition that causes ...

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had dropped to 60 percent as half of her lung had collapsed and was scarred shut.

Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The damage tends to get worse ...